EAU Update on Prostate Cancer Go to the Virtual Platform Register now!

Static homepage

PCa21, the 5th EAU Update on Prostate Cancer will be held virtually again! We are pleased to announce that on 16 October 2021, there will be an afternoon virtual event on prostate cancer.

The PCa21 Virtual Update, which is a collaboration with the European School of Urology, will include case discussions, debates, guidelines news and have a highly interactive character with ample opportunity for audience questions. Experts of the field will give a complete and practical update on all the latest developments in prostate cancer management.

The meeting preserves the educational and interactive format of previous PCa Updates. Strongly rooted in clinical practice, four case-based sessions will cover locally advanced and metastatic prostate cancer and genetic in clinical management of prostate cancer. You can also expect updates on the latest relevant EAU Guidelines for 2021.

Looking forward to be welcoming you virtually again!

Go to the Virtual Platform

Prof. Morgan Rouprêt ESOU Chairman

Prof. Morgan Rouprêt
PCa21 Steering committee

Prof. Dr. Arnulf Stenzl
PCa21 Steering committee

Why you should attend this congress

In-depth, expert-led discussions

PCa21 features only the most experienced faculty. Thanks to collaboration with the European School of Urology, the meeting has a strong educational character.

Interactive and unique

The meeting is designed to give participants a complete update on PCa, and does so in case-based fashion with practical implications. Audience participation is encouraged through the Q&A feature.

All-encompassing coverage

PCa21’s programme is designed to offer vital developments in risk stratification, treatment strategies for oligometastatic and metastatic PCa, the role of genetic in clinical management, and more.

EAU on Twitter

Prostate biopsy is one of the most common urological procedures. Antimicrobial resistance is increasing in incidence.

Make your intention infection prevention! Follow #EAUguidelines to prevent the extent & morbidity of #urologicalinfections after #prostatebiopsy.

Thank you for your participation at #PCa21 👏 You can (re)watch the sessions via the On Demand feature of the Virtual Platform as soon as they become available. CME-credited access to the sessions is available until 16 Jan. 2022 (17:15 CET).

Here are some #guidelines recommendations on #mCRPC that Prof. Mottet presented during his #PCa21 lecture on “Upfront use: Use in the CRPC situations”.



(1/2) In his #PCa21 lecture “Germline mutations in prostate cancer: What to search and in whom?”, Dr. @quimmateo stated: "Identification of patients with germline mutations leads to the identification of healthy individuals carrying mutations at...

Prof. @philcornford: "ctDNA testing can also be considered for somatic mutations, but testing is not widely available and needs to be of high sensitivity. Careful attention to potential false positive and false negative results is required."


Load More...